Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.64
S.64: Preserve Access to Affordable Generics and Biosimilars Act
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Jan. 9, 2019
- Latest Major Action Jan. 9, 2019
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
7 (3 Democrats, 4 Republicans)
Bill Version
- Introduced in Senate - Jan. 9, 2019
Bill Summary
Preserve Access to Affordable Generics and Biosimilars Act This bill authorizes the Federal Trade Commission (FTC) to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement is presumed to have anticompetitive effects and is a violation of this bill if the filer of the generic drug or biosimilar application receives...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| Jan. 9, 2019 |
Read twice and referred to the Committee on the Judiciary.
|
| Jan. 9, 2019 |
Introduced in the Senate by Amy Klobuchar (D-Minn.) |